During the past decade, Northern Michigan Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 32 clinical trials were completed, i.e. on average, 290.9% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 8 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northern Michigan Hospital" #1 sponsor was "SWOG Cancer Research Network" with 21 trials, followed by "Boston Scientific Corporation" with 13 trials sponsored, "Abbott Medical Devices" with 9 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored and "Radiation Therapy Oncology Group" with 5 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northern Michigan Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 35 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator, "Eli Lilly and Company" with 4 trials as a collaborator and "NRG Oncology" with 4 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Northern Michigan Hospital" are "Coronary Artery Disease" (22 trials), "Breast Cancer" (12 trials), "Coronary Artery Stenosis" (6 trials), "Coronary Disease" (5 trials) and "Prostate Cancer" (5 trials). Many other conditions were trialed in "Northern Michigan Hospital" in a lesser frequency.

Most popular intervention types in "Northern Michigan Hospital" are "Drug" (45 trials), "Device" (30 trials), "Biological" (13 trials), "Other" (12 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "cyclophosphamide" (5 trials), "paclitaxel" (5 trials), "placebo" (5 trials) and "cetuximab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Northern Michigan Hospital" are 67 trials for "All" genders, 12 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Northern Michigan Hospital". undefined are not yet recruiting, 1 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 64 completed trials in Northern Michigan Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Northern Michigan Hospital, 0 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 41 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 14 trials that are defined as “Not Applicable".

Northern Michigan Hospital has several departments that took part in Clinical trials: "Michigan Heart and Vascular Specialists" - 3 trials